Here's Why You Should Add Avantor Stock to Your Portfolio for Now
AVTR's improving commercial execution, specialty product strength and raised 2026 outlook signal recovery potential despite lingering demand challenges.
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
AVTR expands its RIM single-use bioprocessing portfolio across APAC, boosting access to locally made solutions and supporting its bioprocessing growth push.
Here's Why You Should Add Avantor Stock to Your Portfolio for Now
AVTR's strong Q2 results, improving orders and raised 2026 outlook support growth prospects, though BMP weakness and uneven demand remain concerns.
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?
Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?
AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.
Is Avantor (AVTR) Outperforming Other Medical Stocks This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Avantor (AVTR) This Year?
Here is how Avantor, Inc. (AVTR) and Johnson & Johnson (JNJ) have performed compared to their sector so far this year.
Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?
Avantor, Inc. (AVTR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AVTR's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
AVTR tops Q2 earnings and revenue estimates as VWR returned to organic growth early, prompting higher 2026 revenues and earnings guidance.
Avantor Q2 Earnings Call Highlights
Avantor NYSE: AVTR reported second-quarter 2026 results that exceeded its expectations on several measures, supported by a return to organic growth in its VWR Distribution & Services segment, strong free cash flow and progress under its Revival operational improvement program.
Avantor (AVTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
